| Turkish Journal of Cancer |
| 2003, Volume 33, Number 3 |
| 53 article(s) found. |
The prognostic predictors for disease free survival and overall survival in stage I-III breast cancer patients treated with adjuvant cyclophosphamide-adriamycin-5-fluorouracil (CAF) chemotherapy BAŞAK OYAN1, NİLÜFER GÜLER1, AYŞE KARS1, ALEV TÜRKER1, KADRİ ALTUNDAĞ1, YAVUZ ÖZIŞIK1, EŞMEN BALTALI1, İSMAİL ÇELİK1, İBRAHİM BARIŞTA1, İBRAHİM GÜLLÜ1, ŞUAYİB YALÇIN1, ERHAN HAMALOĞLU2, ZAFER ÖNER2, GÜLTEN TEKUZMAN1 |
Early detection and treatment of skin cancer PETER TROVITCH, ANSHUL GUPTE, KADRIYE CİFTCİ |
A retrospective analysis of 32 locally advanced nasopharyngeal carcinoma patients treated with chemotherapy and radiotherapy AHMET ÖZET1, MURAT BEYZADEOĞLU2, YILMAZ TEZCAN1, FİKRET ARPACI1, BEKİR OZTÜRK1, ALİ AYDIN YAVUZ1, ŞEREF KÖMÜRCÜ1, M İLKER YILMAZ3, KAAN OYSUL2 |
Resection of retroperitoneal residual mass after chemotherapy in patient with nonseminomatous testicular cancer AHMET ÖZET1, ALİ AYDIN YAVUZ1, MURAT BEYZADEOĞLU3, YAŞAR ÖZGÖK4, BEKİR ÖZTÜRK1, FİKRET ARPACI1, ŞEREF KÖMÜRCÜ1, LEVENT YAMANEL2, TEOMAN DOĞRU2 |
The acute effects of chemotherapy upon the oral cavity: Prevention and management TUNÇ İLGENLİ1, HALE ÖREN2, KAMER UYSAL2 |
High-dose chemotherapy with non-cryopreserved autologous peripheral stem cell transplantation in refractory/relapsed testicular carcinoma: Single center results ORHAN TÜRKEN, AHMET ÖZTÜRK, MUSTAFA YAYLACI, BÜLENT ORHAN, NECDET ÜSKENT |
Lipiodol chemoembolization and additional tamoxifen and verapamil as chemosensitizers in unresectable hepatocellular carcinoma with immunohistochemically P-glycoprotein positive case HASAN ÜSTÜN1, MELEK ÜSTÜN2, TİMUR SİNDEL3, SAİM YILMAZ3, HAKAN BOZCUK4, GÜLTEN KARPUZOĞLU4, BURHAN SAVAŞ4 |
Leiomyosarcoma of the rectum: Report of two cases BERNA ÖKSÜZOĞLU1, NİLÜFER GÜLER1, AYŞEGÜL ÜNER2, ERHAN HAMALOĞLU3 |
Two different clinical presentations of infantile fibrosarcoma TİRAJE CELKAN1, ALP ÖZKAN1, HİLMİ APAK1, BİROL HALİL İBRAHİM1, SERGÜLEN DERVİŞOĞLU2, LEBRİZ YÜKSEL1, İNCİ YILDIZ1 |
Nasopharyngeal carcinoma case with glutathione-S-transferase-p positivity by immunohistochemistry HASAN ÜSTÜN1, MELEK ÜSTÜN2, GÜLTEN KARPUZOĞLU3, BURHAN SAVAŞ4 |
Amelanotic malignant melanoma of the vagina ŞAHANDE ELAGÖZ, DİLEK SEMA ARICI, HANDAN AKER, ABDULLAH TAŞYURT, GÜLHAN ARIKAN |
RESULTS OF HIGH DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (APBSCT) IN 45 PATIENTS WITH BREAST CANCER AHMET ÖZET1, FİKRET ARPACI1, BEKİR ÖZTÜRK1, CELALETTİN CAMCI2, MÜKERREM SAFALI1, ŞEREF KÖMÜRCÜ1, BÜLENT GÜLEÇ3, İLKER YILMAZ1, HASAN AYTA1, A AYDIN YAVUZ1, YÜCEL PAK1, İDRİS YÜCEL4, ATİLLA YALÇIN2 |
Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma GONCA BOZTEPE ŞENTÜRK, SEDEF ŞAHİN |
The effect of radiation therapy in limited small cell lung cancer KAYHAN ENGIN, LÜTFİ ÖZKAN, OKTAY İNCEKARA |
Yolk Sac Tumor (A Clinical and Therapeutical Analysis of 9 Cases) S. GÖZDAŞOĞLU, A. PAMİR, A. O. ÇAVDAR, E. ÜNAL, ÖMER ULUOĞLU, G. YAVUZ, E. BABACAN, İ. H. GÖKÇORA, U. GÜR |
COPP Chemotherapy in the Treatment of Advanced Hodgkin’s Disease MEHMET ALAKAVUKLAR, GÜLTEN TEKUZMAN, EŞMEN BALTALI, ŞEVKET RUACAN, EMİN KANSU, AYŞE KARS, YAVUZ ÖZIŞIK, DİNÇER FIRAT, ERGUN KARAAĞAOĞLU |
CEF Combination as Neoadjuvant Therapy in Stage III Breast Cancer Patients EŞMEN BALTALI, SAİME AYŞE KARS, ZAFER ÖNER, YAVUZ ÖZIŞIK, NİLÜFER GÜLER, GÜLTEN TEKUZMAN, DİNÇER FIRAT, İSKENDER SAYEK |
Acute Lymphoblastic Leukemia in Breast Cancer: A Case Report YENER KOÇ, SAİME AYŞE KARS, EMİN KANSU, DİNÇER FIRAT |
Paratesticular rhabdomyosarcoma in children FAİK SARIALİOĞLU1, İNCİ İLHAN1, AKGÜN HİÇSÖNMEZ2, CANAN AKYÜZ1, TEZER KUTLUK1,MÜNEVVER BÜYÜKPAMUKÇU1 |
Single-agent and combination chemotherapy in small cell lung cancer ÖZGÜR ÖZYILKAN1, GÜLTEN TEKUZMAN1, AYŞE KARS1, İBRAHİM BARIŞTA1, EŞMEN BALTALI1, ŞEVKET RUACAN2, YAVUZ ÖZIŞIK1, EMİN KANSU1, DİNÇER FIRAT1 |
A randomized study of 5-fluorouracil containing chemotherapy regimens in patients with advanced colorectal carcinoma MELEK ERKİŞİ1, DİLAVER AĞDEMİR2, REFİK BURGUT3, FİGEN DORAN4, SEYHAN VARİNLİ4 |
The role of bleomycin, cyclophosphamide, mitoxantrone, vincristine and prednisone (BCNOP) in non-Hodgkin’s lymphoma YAVUZ ÖZlŞlK, AYŞE KARS, İBRAHİM BARIŞTA, GÜLTEN TEKUZMAN, EMİN KANSU, DİNÇER FIRAT |
The role of b-interferon plus melphalan and prednisolone in untreated patients with multiple myeloma NAHİDE KONUK, BEKİR YAZAN, İSMET AYDOĞDU |
Cyclophosphamide, epirubicin, and etoposide alternating with cisplatin and etoposide in small cell lung cancer ÖZGÜR ÖZYILKAN, AYŞE KARS, GÜLTEN TEKUZMAN, EŞMEN BALTALI, DİNÇER FIRAT |
5-Fluorouracil, adriamycin and mitomycin-C combination chemotherapy for advanced gastric carcinoma İBRAHİM GÜLLÜ, GÜLTEN TEKUZMAN, EŞMEN BALTALI, İBRAHİM BARIŞTA, AYŞE KARS, NİLÜFER GÜLER, GÖRGÜN AKPEK, DİNÇER FIRAT |
Metastatic malignant melanoma in bone marrow: importance of aspiration cytology İLHAN TUNCER1, SEMRA PAYDAŞ2, EDİZ F. COŞAR1, CANAN ERSÖZ1 |
High dose cytosine arabinoside + mitoxantrone or mitoxantrone + etoposide in refractory or early relapsed acute non-Iymphoblastic leukemia: 5 years experience in İbn-i Sina Hospital OSMAN İLHAN, HALUK KOÇ, MERAL BEKSAÇ, HAMDİ AKAN, NAHİDE KONUK, ÖNDER ARSLAN, GÜNHAN GÜRMAN, MUHİT ÖZCAN, AKIN UYSAL, ORHAN SEYFİ SARDAŞ |
Analysis of 123 patients with non-Hodgkin’s lymphoma: experience of Ege University Medical School ALİ KESKİN1, MURAT TOMBULOĞLU2, SEÇKİN ÇAĞIRGAN2, FİLİZ BÜYÜKKEÇECİ2, MEVLÜT TÜRE3 |
High dose epirubicin and ifosfamide alternating with etoposide and cisplatin therapy with granulocyte macrophage colony stimulating factor in small cell lung cancer ÖNDER BERK1, HALUK ONAT2, AYŞE KARS3, SÜHEYLA SERDENGEÇTİ4, NAZAN GÜNEL5, FARUK AYKAN2, SAİT OKKAN4, MÜNİR KINAY6, NECDET ÜSKENT7, GÜRSEL AKTAN8, DİNÇER FIRAT3 |
Weekly doses of epirubicin in locally advanced breast cancer patients as neoadjuvant chemotherapy EŞMEN BALTALI, FİKRİ İÇLİ, NİL MOLİNAS MANDEL, HALUK ONAT, GÜRSEL AKTAN, AHMET OBER, NECDET ÜSKENT, MÜNİR KINAY,ÖNDER BERK, DİNÇER FIRAT |
Combination chemotherapy involving weekly epirubicin in the treatment of intermediate and high grade non-Hodgkin’s lymphomas DİLEK DİNÇOL, NİL MANDEL MOLİNAS, İBRAHİM BARIŞTA, GÜRSEL AKTAN, HALUK ONAT, ORHAN SEYFİ SARDAŞ, ÖNDER BERK, CAVİT ÇEHRELİ, DİNÇER FIRAT |
Paratesticular rhabdomyosarcoma MEHMET CEMİL UYGUR1, ALİ İHSAN ARIK1, LALE KUTLUAY2, ERDURAN GÜR1, YÜCEL GÜNGEN3, DEMOKAN EROL1 |
Current management of diffuse aggressive lymphomas: Role of dose-intensive chemotherapy and peripheral stem cell/marrow transplantation-I YENER KOÇ |
Myeloprotective effect of high dose medroxyprogesterone acetate on patients receiving cytotoxic chemotherapy MUSTAFA SAMUR, FİKRİ İÇLİ, HAKAN AKBULUT, AHMET DEMİRKAZIK, FİLİZ ÇAY, ALİ ARICAN |
Treatment strategies for malignant melanoma MUHAMMAD S. AKHTAR and WALLACE L. AKERLEY |
Veno-occlusive disease of the liver after chemotherapy for acute lymphoblastic leukemia: a case report GÜL SERDAROĞLU1, ERKİN SERDAROĞLU1, SERTAÇ ARSLANOĞLU1, RAGIP ORTAÇ2, NESRİN UMUTLU1, ERTAN KAYSERİLİ1, PAMİR GÜLEZ1, CANAN VERGİN3 |
Primary extramedullary plasmacytoma of the liver NİLÜFER GÜLER, ALEV TÜRKER |
Is the third-line chemotherapy feasible for non-small cell lung cancer? A retrospective study MUSTAFA ÖZDOĞAN, MUSTAFA SAMUR, HAKAN BOZCUK, ERKAN ÇOBAN, MEHMET ARTAÇ, BURHAN SAVAŞ |
Venlafaxine for treatment of chemotherapy-induced neuropathic pain MUSTAFA ÖZDOĞAN1, MUSTAFA SAMUR1, HAKAN Ş. BOZCUK1, HÜLYA AYDIN2, ERKAN ÇOBAN1,BURHAN SAVAŞ1 |
Evaluation of Tumor Necrosis Factor-α (TNF-α), soluble P-selectin (sP-Selectin), gamma-glutamyl transferase (GGT), glutathione S-transferase Pi (GST-Pi) and alphafetoprotein (AFP) in patients with hepatocellular carcinoma before and during chemotherapy MERVAT MOUSTAFA1, MOHAMED MORSİ2, AMİNA HUSSEİN3, EMAN AL ABD2, NADİA ABDEL MONEİM2 |
The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report MUTLU DEMİRAY1, TÜRKKAN EVRENSEL1, ÖZKAN KANAT1, ENDER KURT1, MURAT ARSLAN1, ÖZLEM SARAYDAROLU2, İLKER ERCAN3, GÜZİN GÖNÜLLÜ1, ŞEHSUVAR GÖKGÖZ4, ŞAHSİNE TOLUNAY2, AYŞE GÖZKAMAN1, NALAN AKGÜL1, İSMET TAŞDELEN4, OSMAN MANAVOLU1 |
The efficacy of preoperative cisplatin and 5-fluorouracil combination in patients with stage III squamous cell carcinoma of the esophagus SERDAR HAN1, BÜLENT YALÇIN2, HAKAN AKBULUT2, İLKER ÖKTEN3 |
Serum tumor markers in small cell lung carcinoma patients treated with cyclophosphamide, epirubicin and vincristine combination HASAN ŞENOL COŞKUN1, ÖZLEM ER2, MUSTAFA ALTINBAŞ2, METİN ÖZKAN2, SERDAR SOYUER2 |
The effect of EGFR overexpression in inoperable non-small cell lung cancer (NSCLC) patients receiving cisplatinvinorelbine combination MAHMOUD A. SALAM1, TAMER ELNAHHAS1, HATEM A. AZIM2, SAMY ALSIRAFY1 |
Delayed molgramostim administration after autologous peripheral blood stem cell transplantation does not add any benefit regarding hematological engraftment and supportive therapy requirements: A prospective randomized trial OKAN KUZHAN, FİKRET ARPACI, AHMET ÖZET, BEKİR ÖZTÜRK, ŞEREF KÖMÜRCÜ |
Evaluation of efficacy and toxicity of systemic chemotherapy of combined epirubicin, cisplatin and bolus 5- fluorouracil for hepatobiliary tumors GÜZİN GÖNÜLLÜ1, TÜRKKAN EVRENSEL2, ENDER KURT2, MUTLU DEMİRAY2, MURAT ARSLAN2, ÖZKAN KANAT2, ABDULLAH ZORLUOĞLU3, OSMAN MANAVOĞLU2 |
Short-term health-related quality of life with epirubicin and cyclophosphamide (EC) versus 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as adjuvant chemotherapy in Turkish patients with operable breast cancer BİNNAZ DEMİRKAN1, TUĞBA YAVUZŞEN1, MEHMET ALAKAVUKLAR2 |
Single-agent vinorelbine as third-line chemotherapy for refractory non-small cell lung cancer ÖZKAN KANAT1, FATİH ÖLMEZ2, ENDER KURT1, ABDÜLMECİT YILDIZ2, TÜRKKAN EVRENSEL1, ELVAN KANAT3, OSMAN MANAVOĞLU1 |
Neoadjuvant chemotherapy and concomitant boost radiotherapy in locally advanced non-small cell lung cancer DENİZ MEYDAN, ŞABAN ÇAKIR, NİLGÜN ÖZBEK, BİLGE GÜRSEL, ÖZDEN KARAOĞLANOĞLU |
Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) in unresectable or metastatic gastric cancer: A single institution experience GÜZİN GÖNÜLLÜ, BURCU ÇAKAR, FATİH ARSLAN, İDRİS YÜCEL |
Primary malignant melanoma at esophagogastric junction EMİN TAMER ELKIRAN1, SELMAN ÇELEBİ1, BİLGE AYGEN1, AZİZ KARAOĞLU1, İBRAHİM ÖZERCAN2 |
Primary intracranial solitary melanoma: A rare case with long survival CEM ÖNAL1, GÖKHAN ÖZYİĞİT2, SERAP AKYÜREK3, UĞUR SELEK2, ENİS ÖZYAR2, İ. LALE ATAHAN2 |
Relapse of testicular cancer after 15 years SERCAN AKSOY1, HAKAN HARPUTLUOĞLU1, SAADETTİN KILIÇKAP1, BÜLENT AKDOĞAN2, HUSEYİN ABALI3, MUSTAFA ERMAN1 |
|
Turkish Journal of Cancer web sitesi Novartis Onkoloji'nin karşılıksız eğitim katkılarıyla hazırlanmıştır.
|